✦ LIBER ✦

Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting

✍ Scribed by Vijay R. Kini; Julia R. White; Eric M. Horwitz; Carl F. Dmuchowski; Alvaro A. Martinez; Frank A. Vicini

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 80 KB
Volume: 82
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19980101)82:1<127::aid-cncr15>3.0.co;2-4

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Prospective randomized trials and retrospective reviews from aca-

📜 SIMILAR VOLUMES

A randomized trial of long term adjuvant

A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery

✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w

Primary axillary radiotherapy as axillar

Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes

✍ Frank J. P. Hoebers; Jacques H. Borger; Augustinus A. M. Hart; Johannes L. Peter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

The objective of the current study was to evaluate the effectiveness and morbidity of primary axillary radiotherapy in breast-conserving therapy for postmenopausal, clinically axillary lymph node negative patients with early stage breast carcinoma. Between 1983-1997, 105 patients with clinically neg

Results and long term follow-up for 1581

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy : A reference

✍ Zia U. Rahman; Debbie K. Frye; Terry L. Smith; Lina Asmar; Richard L. Theriault; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

The authors report results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with doxorubicin-containing combination chemotherapy at a single institution; this report is meant to serve as a reliable reference for single-arm studies of newer therapies in this patient

Breast conservation therapy in the Unite

Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma

✍ DeAnn Lazovich; Cam C. Solomon; David B. Thomas; Roger E. Moe; Emily White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of breast conserv